摘要
目的:探讨阿奇霉素及氨溴索注射液在肺炎支原体肺炎患儿中的临床疗效。方法:2016年6月-2017年6月收治支原体肺炎患儿80例,根据治疗方案不同分为两组各40例。对照组给予阿奇霉素治疗,观察组在对照组基础上联合氨溴索注射液治疗。观察两组临床疗效、住院时间、症状恢复时间以及不良反应。结果:观察组总有效率明显高于对照组,住院及退热时间、啰音和咳嗽消失时间短于对照组,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:阿奇霉素及氨溴索注射液治疗支原体肺炎患儿疗效显著,能明显提高临床疗效,缩短治疗时间,改善预后,值得在临床推广。
Objective:To explore the application and effect of azithromycin and ambroxol injection in children with mycoplasma pneumonia.Methods:From June 2016 to June 2017,we selected 80 cases of children with mycoplasma pneumonia.According to the treatment plan,they were divided into two groups of 40 cases in each.The control group was treated with azithromycin,the observation group was treated with ambroxol injection on this basis.We observed the clinical efficacy,hospital stay,symptom recovery time and adverse reactions of the two groups.Results:There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).In the observation group,the total effective rate was significantly higher than that in the control group,the hospitalization and fever reduction time,rales and cough disappearance time were shorter than those in the control group,the difference was statistically significant(P<0.05).Conclusion:The efficacy of azithromycin and ambroxol injection in the treatment of children with mycoplasma pneumonia was significant,it can obviously improve the clinical efficacy,shorten the treatment time and improve the prognosis,which was worth popularizing.
作者
邱玲
Qiu Ling(Suzhou Science and Technology City Hospital Affiliated to Nanjing Medical University,Jiangsu,Suzhou 215153)
出处
《中国社区医师》
2019年第34期50-51,共2页
Chinese Community Doctors
关键词
阿奇霉素
氨溴索
支原体肺炎
Azithromycin
Ambroxol
Mycoplasma pneumonia
